Netflix announced its modified all-cash bid for Warner Bros. Discovery on Tuesday after Paramount Skydance continued to threaten a hostile takeover of the Hollywood studio. Warner Bros. is trying to ...

Some of the country’s most pressing problems have a simple solution — remove the regulatory obstacles that slow progress. One obvious example is housing. The best way to reduce the cost of housing isn ...

Jan 6 (Reuters) - Variant Bio, a private biotech firm, said on Tuesday it has launched a platform that uses artificial intelligence on genetic data to discover new drug candidates to send into human ...

Matthew Lees is supported by a Canadian Institutes of Health Research (CIHR) Postdoctoral Fellowship award (Funding Reference Number 187773). Tom Janssen does not work for, consult, own shares in or ...

Alex Zhavoronkov, Founder and CEO of generative-AI drug discovery firm Insilico Medicine, discusses the company's plans after it raised $293 million in its initial public offering in Hong Kong. He ...

The search for life on Earth is speeding up, not slowing down. Scientists are now identifying more than 16,000 new species each year, revealing far more biodiversity than expected across animals, ...

A private equity firm owned by President Donald Trump's son-in-law, Jared Kushner, pulled its financial backing on Tuesday from Paramount’s $108 billion hostile takeover bid to acquire Warner Bros.

Eli Lilly has unveiled the location of the third of its four large-scale manufacturing facilities that it plans to build in the U.S. The drugmaker has selected Huntsville, Alabama, as the site of a $6 ...

President Donald Trump raised antitrust concerns over the proposed Netflix takeover of Warner Bros. Discovery on Sunday, warning that the combined market share could be a problem. Netflix on Friday ...

Beryl Rappaport, a microbiologist completing her Ph.D. at Syracuse University, and a team of researchers identified a new eukaryote, a type of amoeba whose cells have a membrane-bound nucleus, that ...

Netflix struck a deal to buy one of Hollywood’s most storied studios. But a scorned rival, and the Trump administration, may put up a fight. By Andrew Ross Sorkin Bernhard Warner Sarah Kessler Michael ...